Multicenter Phase I/Ib Trial of Olaparib in Combination With Vorinostat in Patients With Relapsed/Refractory and/or Metastatic Breast Cancer

Project: Clinical Trial

Project Details

StatusActive
Effective start/end date2/9/21 → …